Lucid Group Inc

NASDAQ: LCID
$2.01
-$0.07 (-3.4%)
Closing Price on November 15, 2024

LCID Articles

The strong report from Tesla on fourth-quarter deliveries lifted share prices for other electric vehicle makers, both domestic and foreign.
Thursday’s top analyst upgrades and downgrades included Amazon.com, APA, Coupang, FuelCell Energy, GlobalFoundries, Lucid, Meta Platforms (Facebook) and Virgin Galactic.
Monday afternoon's top analyst upgrades and downgrades included Activision Blizzard, Lucid, Nokia, Pfizer, SoFi Technologies, Sunrun and Welltower.
An electric motorcycle spin-off and a Time magazine Person of the Year get the week off to a busy start.
CEO stock sales have had a negative effect on share prices for a couple of well-known meme stocks.
Tesla is in a bit of hot water with U.S. regulators, and nobody seems to want to own stock in Southeast Asia's superapp, except the big guys that already control nearly 50% of the shares.
A new meme stock ETF debuted on Wednesday. The fund's top holding is Digital World Acquisition, the SPAC that is taking Donald Trump's ostensible media company public.
Reduced concern for the impact of the Omicron variant of the coronavirus lifted stocks higher on Monday. The effect appeared to be continuing in Tuesday's premarket trading.
A couple of SEC investigations have cooled off share prices for some popular meme stocks.
Meme stocks took a beating on Friday, and Monday did not appear to be getting off to a better start.
Markets traded higher Wednesday morning, dragging some of the meme stocks along for the ride. In the early afternoon, though, the day's gains had been pared down.
An FDA directive has hammered a coronavirus vaccine maker Friday morning as a new variant of the infection is discovered in South Africa.
Here's a look at why five favorite retail stocks were all trading up by double digits at noontime Friday.
Nearly every electric vehicle stock traded lower Thursday, as investors likely were pocketing some profits on the recent runup in these stocks.
EV stocks were losing some of their recent gains, and one biotech has announced a new federal investigation.